Quick10K

⚲

MedAmerica Properties

Filings

10-K	2019-12-31	Filed 2020-12-22
10-Q	2019-09-30	Filed 2019-11-12
10-Q	2019-06-30	Filed 2019-08-12
10-Q	2019-03-31	Filed 2019-05-14
10-K	2018-12-31	Filed 2019-04-11
10-Q	2018-09-30	Filed 2018-11-13
10-Q	2018-06-30	Filed 2018-08-03
10-Q	2018-03-31	Filed 2018-05-14
10-K	2017-12-31	Filed 2018-04-02
10-Q	2017-09-30	Filed 2017-11-20
10-Q	2017-06-30	Filed 2017-08-14
10-Q	2017-03-31	Filed 2017-05-15
10-K	2016-12-31	Filed 2017-03-31
10-Q	2016-09-30	Filed 2016-11-14
10-Q	2016-06-30	Filed 2016-08-12
10-Q	2016-03-31	Filed 2016-05-13
10-K	2015-12-31	Filed 2016-03-22
10-Q	2015-09-30	Filed 2015-11-06
10-Q	2015-06-30	Filed 2015-08-05
10-Q	2015-03-31	Filed 2015-05-13
10-K	2014-12-31	Filed 2015-03-25
10-Q	2014-09-30	Filed 2014-11-19
10-Q	2014-06-30	Filed 2014-08-14
10-Q	2014-03-31	Filed 2014-05-15
10-K	2013-12-31	Filed 2014-03-27
10-Q	2013-09-30	Filed 2013-11-13
10-Q	2013-06-30	Filed 2013-08-02
10-Q	2013-03-31	Filed 2013-08-01
10-K	2012-12-31	Filed 2013-03-25
10-Q	2012-09-30	Filed 2012-11-19
10-Q	2012-06-30	Filed 2012-08-14
10-Q	2012-03-31	Filed 2012-05-15
10-K	2011-12-31	Filed 2012-03-28
10-Q	2011-09-30	Filed 2011-11-14
10-Q	2011-06-30	Filed 2011-08-15
10-Q	2011-03-31	Filed 2011-05-13
10-K	2010-12-31	Filed 2011-04-04
10-Q	2010-09-30	Filed 2010-11-15
10-Q	2010-06-30	Filed 2010-08-16
10-Q	2010-03-31	Filed 2010-05-24
10-K	2009-12-31	Filed 2010-04-15

Reports

8-K	2020-07-02
8-K	2020-06-16
8-K	2020-05-12
8-K	2020-01-16
8-K	2020-01-10
8-K	2019-12-31
8-K	2019-12-27
8-K	2019-11-27
8-K	2019-05-28
8-K	2019-05-16
8-K	2019-01-30
8-K	2018-11-27
8-K	2018-09-13
8-K	2018-05-23

MedAmerica Properties Financials

MAMP Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin


Comps ($'000 TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
ENETI INC. (NETI)
024 Pharma (EEIG)
Vivus (VVUS)	40,869	77%	-17.5	-11%	226,103	289,374	72,620	55,706	-24,956	-13,928	243,484
Clovis Oncology (CLVS)	219,222	0%	-0.0	-56%	716,892	804,387	134,050	0	-400,184	-394,255	17,741
Cementos Pacasmayo Saa (CPAC)	4,145,433			0%	2,863,245	1,411,882	0	0	0	0	4,145,433
11 Good Energy (ELVN)
Exantas Capital (XAN)
1347 Capital Corp (TFSC)
Bancorp of New Jersey (BKJ)	122,881		1.0	0%	961,684	868,577	0	0	3,422	14,772	14,360
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
1st United Bancorp (FUBC)
2-Track Global (TTG)
ENTERGY ARKANSAS, LLC (EAI)
21st Century Oncology Holdings (RTSX)
24Holdings (TWFH)
30DC (TDCH)
3D Pioneer Systems (DPSM)
ALABAMA POWER CO (APRCP)


Balance Sheet ($'000)	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	136	314	8	19	0	6	8	2	48	27	2	5	6	402	516	491	458	327	181	61	60	0	673	1,324	1,152	708	479	358	262	140	76	5	32
Accounts Receivable	450	448	823	1,056	636	319	0	0	0	0
Inventory				307	484	0
PP&E	2,875	2,650	3,302	3,266	2,968	2,733	2	1	0	0															23	23	23	23	23	23	23	23	23
Assets	11,148	11,400	12,970	13,538	10,171	3,142	22	16	48	38	13	17	6	402	516	491	466	336	191	72	163	142	695	1,338	1,200	768	531	431	328	192	118	33	59
Accounts Payable						984				30	58	77	85	34	29	31	32	42	67	75	50	62	67
Long-Term Debt	2,848	2,487	2,880	4,252	4,258	3,898
Liabilities	6,517	6,612	8,231	8,877	6,743	6,838	564	-759	431	601	598	855	684	309	260	280	288	309	329	375	669	897	450	180	234	127	99	86	116	153	199	259	295
Stockholders' Equity	4,631	4,788	4,739	4,661	3,428	-2,851	-542	775	-383	-563	-584	-837	-678	93	256	211	179	27	-138	-303	-505	-755	244	1,159	966	642	432	345	212	39	-81	-226	-235


Income Statement ($'000)	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue	1,056	1,314	679	974	2,778	1,487
Cost of Revenue	940	815	309	765	3,304	2,831
Gross Profit	116	499	370	463	-527	-1,344
R&D
SG&A	421	375	458	401	506	393	176	103	111	-896	-116	127	60	6,702	133	158	675	139	169	138	338	214	110	114	261	330
Tax		3	0	79	491	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0				6	0	0		0	0	0
Net Income	-388	47	-170	-160	-1,624	-6,748	1,642	3,156	-111	-279	-170	-220	-68	-10,630	-133	-158	-675	-139	-169	-138	-341	-223	-5	219	-263	-331	-209	-87	-134		-120	-145	-9


Cash Flow ($'000)	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating		-101	-314	-593	-357	-341	-290		-34	-394	-75	-96	0	-128	-178	-164	-116	-145	-146		-276	-243	139	-91		-315	-217	-109	-87		-51	-59	36
Cash Investing		372	-636	-183	-128	-77	0	0	0	0																-135	0	0	0
Cash Financing		-93	644	787	465	424	292		80	372	50	100	0	525	292	139	84	14	0		275	184	533	742		7	-12	-12	-8		-12	-12	-8